Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Tempus AI, Inc. - Class A Common Stock (NQ: TEM )

45.96 +3.06 (+7.14%)
Streaming Delayed Price Updated: 2:48 PM EDT, Aug 15, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Tempus AI, Inc. - Class A Common Stock

NPJ Precision Oncology Publishes Tempus Study on Validation of its HLA-LOH Investigational Assay
From Tempus AI, Inc.
Via Business Wire
Tempus Reports Second Quarter 2024 Results
From Tempus AI, Inc.
Via Business Wire
Tempus Next Launches New Algorithm to Close Care Gaps in Guideline-Directed IHC Testing, Starting with HER2
From Tempus AI, Inc.
Via Business Wire
Tempus Announces Expanded Data and Sequencing Collaboration with Remix Therapeutics
From Tempus AI, Inc.
Via Business Wire
Tempus to Report Second Quarter 2024 Financial Results on August 6
From Tempus AI, Inc.
Via Business Wire
Tempus Expands Immuno-Oncology Portfolio with Launch of AI-enabled, Multimodal Immune Profile Algorithmic Tests
From Tempus AI, Inc.
Via Business Wire
Tempus Surpasses 500 Research Publications
From Tempus AI, Inc.
Via Business Wire
American Medical Association Grants PLA Code to Tempus Algorithmic Test, PurISTSM
From Tempus AI, Inc.
Via Business Wire
CMS Awards Tempus With Advanced Diagnostic Laboratory Test (ADLT) Status for its xT CDx Test
From Tempus AI, Inc.
Via Business Wire
Tempus Receives U.S. FDA 510(k) Clearance for Tempus ECG-AF, an AI-based Algorithm that Identifies Patients at Increased Risk of AFib
From Tempus
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.